These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21960080

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.
    Zeng YQ, Xiao J, Li CL, Wang Y, Zhang L, Pang XL, Wang D, Du J, Zhao HX.
    Chin Med J (Engl); 2020 Dec 03; 133(24):2940-2946. PubMed ID: 33278100
    [Abstract] [Full Text] [Related]

  • 43. Low bone mineral density in patients with well-suppressed HIV infection: association with body weight, smoking, and prior advanced HIV disease.
    Kooij KW, Wit FW, Bisschop PH, Schouten J, Stolte IG, Prins M, van der Valk M, Prins JM, van Eck-Smit BL, Lips P, Reiss P, AGEhIV Cohort Study group.
    J Infect Dis; 2015 Feb 15; 211(4):539-48. PubMed ID: 25180239
    [Abstract] [Full Text] [Related]

  • 44. Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.
    Sharma A, Flom PL, Weedon J, Klein RS.
    AIDS; 2010 Sep 24; 24(15):2337-45. PubMed ID: 20683316
    [Abstract] [Full Text] [Related]

  • 45. Low bone mineral density, regardless of HIV status, in men who have sex with men.
    Grijsen ML, Vrouenraets SM, Wit FW, Stolte IG, Prins M, Lips P, Reiss P, Prins JM.
    J Infect Dis; 2013 Feb 01; 207(3):386-91. PubMed ID: 23148289
    [Abstract] [Full Text] [Related]

  • 46. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M, Klomberg RCW, van der Veer E, Tesselaar K, Verhaar HJJ, Hoepelman AIM, Arends JE.
    Neth J Med; 2017 May 01; 75(4):138-144. PubMed ID: 28522769
    [Abstract] [Full Text] [Related]

  • 47. Bone mineral density loss, osteoporosis, and fractures in HIV.
    Labarga P.
    AIDS Rev; 2013 May 01; 15(3):189-90. PubMed ID: 24002203
    [Abstract] [Full Text] [Related]

  • 48. The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.
    Pepe J, Isidori AM, Falciano M, Iaiani G, Salotti A, Diacinti D, Del Fiacco R, Sbardella E, Cipriani C, Piemonte S, Romagnoli E, Lenzi A, Minisola S.
    Clin Endocrinol (Oxf); 2012 Nov 01; 77(5):672-8. PubMed ID: 22630782
    [Abstract] [Full Text] [Related]

  • 49. Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART.
    Landonio S, Quirino T, Bonfanti P, Gabris A, Boccassini L, Gulisano C, Vulpio L, Ricci E, Carrabba M, Vigevani GM.
    Biomed Pharmacother; 2004 Nov 01; 58(9):505-8. PubMed ID: 15511607
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Decreased bone mineral density in HIV-infected children receiving highly active antiretroviral therapy].
    Rojo Conejo P, Ramos Amador JT, García Piñar L, Ruano Fajardo C, Sánchez Granados JM, González Tomé MI, Ruiz Contreras J.
    An Pediatr (Barc); 2004 Mar 01; 60(3):249-53. PubMed ID: 14987516
    [Abstract] [Full Text] [Related]

  • 52. [Are bones in HIV-infected patient really fragile?].
    Biver E, Ciaffi L, Rizzoli R, Calmy A.
    Rev Med Suisse; 2013 Jun 12; 9(390):1246-50. PubMed ID: 23821841
    [Abstract] [Full Text] [Related]

  • 53. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.
    Brown TT, Qaqish RB.
    AIDS; 2006 Nov 14; 20(17):2165-74. PubMed ID: 17086056
    [Abstract] [Full Text] [Related]

  • 54. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.
    Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE.
    AIDS; 2000 Mar 10; 14(4):F63-7. PubMed ID: 10770534
    [Abstract] [Full Text] [Related]

  • 55. Low bone mineral density among HIV-infected patients in Brazil.
    Chaba DCDS, Soares LR, Pereira RMR, Rutherford GW, Assone T, Takayama L, Fonseca LAM, Duarte AJS, Casseb J.
    Rev Inst Med Trop Sao Paulo; 2017 Dec 21; 59():e89. PubMed ID: 29267597
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.
    Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P.
    Clin Infect Dis; 2003 Feb 15; 36(4):482-90. PubMed ID: 12567307
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management.
    Bongiovanni M, Tincati C.
    Curr Mol Med; 2006 Jun 15; 6(4):395-400. PubMed ID: 16900662
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.